MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$128,876K
Cash and cash
equivalents
$73,682K
Accounts receivable
$12,484K
Prepaid expenses and
other current assets
$5,930K
Total current assets
$220,972K
Operating lease
right-of-use assets
$9,707K
Property and equipment,
net
$9,363K
Other non-current
assets
$1,088K
Restricted cash
$858K
Total assets
$241,988K
Accumulated deficit
-$1,016,439K
Accumulated other
comprehensive (loss) income
-$101K
Total liabilities and
stockholders' deficit
$241,988K
Total stockholders'
deficit
-$66,887K
Additional
paid-in-capital
$949,636K
Common stock, 0.001 par
value - 300,000,000...
$17K
Total liabilities
$308,875K
Deferred royalty
obligation related to the...
$229,105K
Total current
liabilities
$70,811K
Operating lease liability
- non-current
$6,032K
Other non-current
liabilities
$1,694K
Deferred revenue -
non-current
$1,233K
Accrued expenses and
other current...
$42,973K
Deferred revenue -
current
$9,399K
Operating lease liability
- current
$7,600K
Accounts payable
$5,485K
Accrued compensation
$5,354K
Back
Back
Balance Sheet
SUTRO BIOPHARMA, INC. (STRO)
SUTRO BIOPHARMA, INC. (STRO)
source: myfinsight.com